Linked Life Data

6210629

Source:http://linkedlifedata.com/resource/pubmed/id/6210629

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1982-7-19
pubmed:abstractText
Ribavirin and Rifamycin SV, given from birth to adult life, arrest the loss of suppressor capacity, normally occurring in older SJL mice. The two drugs differ in their effect on Th-2-type help for the indirect plaque-forming response, i.e. for help which is independent of the carrier-hapten bridge. This type of help normally increases with age. Ribavirin treatment inhibits development of Th-2-type of help; Rifamycin SV does not interfere with the development of this type of help. Neither of the two drugs had an effect on the ability of SJL mice, not treated with aggregate-freed RGG, to make a plaque-forming response to aggregated RGG.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0165-2478
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
149-53
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
The effect of ribavirin and rifamycin SV on age-dependent changes of the immune system during the adult life of SJL mice.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't